FDA — authorised 17 June 2009
- Application: BLA125319
- Marketing authorisation holder: NOVARTIS PHARMS
- Local brand name: ILARIS
- Indication: INJECTABLE — SUBCUTANEOUS
- Status: approved
🇺🇸 Ilaris in United States
FDA authorised Ilaris on 17 June 2009
Marketing authorisation
Ilaris in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Ilaris approved in United States?
Yes. FDA authorised it on 17 June 2009.
Who is the marketing authorisation holder for Ilaris in United States?
NOVARTIS PHARMS holds the US marketing authorisation.